C ardiovascular proteomics is a rapidly growing field, especially with the emergence of high-throughput mass spectrometry-based techniques. After the identification of proteins in a given sample, researchers are keen to find out how much of the protein is present, especially in a disease or a given state. Though challenging, over the past few years, several approaches have been established to quantify proteins from cells or tissues at a given state. In this review, we focus on mass spectrometry -based quantitative approaches for both large-scale and targeted proteomic analyses, which can be used in cardiovascular research. Several strategies using labeling and label-free approaches for both relative and absolute quantification (AQUA) have been established to meet the requirements of the researcher. Each of these methods has its own merits and limitations. We will discuss the methods that researchers can opt for to address the biological questions related to cardiovascular research.
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Cardiovascular proteomics is the branch of proteomics specifically applied to heart and vasculature. The field of proteomics has recently gained greater importance based on its potential to unravel the complex physiological and biochemical mechanisms and pathways in organisms and cells at the molecular level. The goal is to identify proteins that generate/mediate disease process, thereby, opening avenues to new diagnostics and therapeutic strategies. Proteins are much closer to the actual disease process, in most cases, than parent genes. They are the ultimate regulators of cell functions, and the vast majorities serve as drug targets. Differential protein expression analysis, by measuring the upregulated or downregulated proteins in disease state as compared with the normal healthy condition, is vital to understand the disease mechanism.
In conjunction with various separation techniques, mass spectrometry (MS)-based methods evolved as the best techniques for the comprehensive characterization of proteins. 1, 2 After the initial protein identification, a more challenging approach in proteomics is the quantification of the proteins identified. 3 Various methods of quantification by MS have been developed recently, for both relative and absolute measurements ( Figure 1 ), and the technology is still expanding to find better and more efficient quantification approaches. This, in turn, is facilitated by the advancements in the MS instrumentation, including powerful analyzers and fragmentation technology. Most of the quantification methods are based on measurements at peptide level and fall under the bottom-up proteomics approach. In this review article, we will outline various MS-based approaches available for measuring the variation in protein abundances and how these techniques are playing a key role in cardiovascular research.
Gel-Based Quantification
Separation of proteins by polyacrylamide gel electrophoresis, followed by MS analysis, has been a common practice in proteomics. With the advent of 2D gel electrophoresis, quantification of proteins is made possible, based on the intensities of protein stains [4] [5] [6] [7] [8] ; however, gel-to-gel variation hinders the researchers to use this approach. The development of 2D fluorescence difference gel electrophoresis (2D-DIGE) overcomes this limitation by making it possible to coseparate and visualize multiple samples on a single 2D gel. In a DIGE experiment, both control and treated samples are differentially labeled with spectrally resolved fluorescent dyes (Cy2, Cy3, and Cy5) and mixed, in equal amounts, to separate on a single 2D gel, for direct quantification. [9] [10] [11] Though quite successful, like any gel-based methods, DIGE has limitations in resolving hydrophobic proteins, interference from high-abundance proteins, and poor resolution of spots with >1 protein, in many cases. In addition, posttranslational modifications and multiple isoforms of proteins often elute in different spots on the gel, complicating the analysis.
In spite of its limitations, this approach is still a preferred method of choice in studies involving large-scale protein analysis. Many studies reported the method to be useful for proteomic characterization and biomarker identification in cardiovascular research. Jacquet et al identified biomarkers of myocardial infarction by DIGE approach. 12 Meng et al applied 2D-DIGE in combination with matrix-assisted laser desorption/ionization (MALDI)-time of flight/time of flight MS to identify alterations in mitochondrial enzymes that contribute to cardiac hypertrophy in spontaneously hypertensive rats. 13 A combined proteomic and metabolomic analysis has been carried out in murine hearts to obtain mechanistic insights of protein kinase C epsilon (PKCϵ)mediated cardioprotection. 14 The proteomic analysis of mitochondrial and cytosolic proteins from control and transgenic hearts, with constitutively active or dominate negative PKCϵ, were analyzed using the DIGE technique for differential protein expression analysis. Fluorescence DIGE has also been used for identifying differential phosphorylation of myosin-binding protein C on myocardial stunning in canine and rat hearts. 15 Several researchers used this method in parallel with other labeling strategies in quantitative studies, and the results reported were found to be comparable. Very recently, Tapio and colleagues studied cardiac tissue of mice to characterize proteins differentially expressed on radiation exposure. 16 They used both 2D-DIGE and isotopecoded protein labeling techniques for a large-scale analysis of cardiac tissue proteome. Fu et al studied redox-sensitive proteins in heart tissues, using both DIGE and isotope-coded affinity tag (ICAT) methods. 17 These isotope-labeling strategies will be discussed in the following sections. An overview of both gel-based and MS-based quantification techniques is depicted in Figure 2 .
Mass Spectrometry-Based Quantification

Relative Quantification Approaches
In recent years, several techniques have been developed for the direct comparison of protein expression levels between 2 or more different samples using mass spectrometry. Ion intensities of the peptides vary largely, owing to the differences in chemical and physical properties of different peptides. Hence, for the quantification of proteins using MS, comparison between different samples can be done by analyzing the same peptides under the same MS conditions. Thus, most of the MS-based quantification strategies rely on relative comparisons between samples. Several relative quantification approaches have been developed recently, which can be categorized into stable isotope-labeling and label-free methods.
Stable Isotope-Labeling
Introduction of a chemically equivalent differential mass tag on the peptide sequence keeps the biochemical and analytical properties of the peptide with its natural counterpart. Except for the mass, it exhibits the same chemical properties during chromatography and, hence, can be used as a relative reference. Relative quantification methods are focused on largescale global proteomics approaches. The workflow comprises of labeling of proteins/peptides with 1 or more stable isotope and pooling the sample in known amounts of unlabeled reference sample. The mixed sample is then subjected to MS analysis. The signal intensities of the labeled and unlabeled peptides are used to measure the relative abundance, while fragmentation of the peptide provides sequence information necessary for the identification of quantified peptide. This approach can be classified into metabolic labeling, chemical mass tagging, and enzymatic labeling.
Metabolic labeling involves the in vivo incorporation of stable isotopes into the protein sequence, supplied through the growth medium during protein biosynthesis. Stable isotope-labeling by amino acids in cell culture (SILAC) was Figure 1 . An overview of mass spectrometry-based quantitative proteomics: Mass spectrometry (MS)-based quantification can be achieved either by relative or absolute quantification (AQUA). Both relative and AQUA can be further classified into labeled and label-free quantification, each of which can be performed by several approaches.
Figure 2.
General depiction of various strategies in differential protein expression analysis: A and B are the gel-based approaches, where 2D gel electrophoresis is performed to identify differential protein expression either on A, separate gels or B, on the same gel with fluorescently labeled proteins. The gel spots of interest are picked and in-gel digested for MS analysis for protein identification. C through F are mass spectrometry (MS)-based quantification approaches classified as C, metabolic; D, enzymatic; E, chemical tagging, and F, label-free approaches, based on the method of quantification. o3 first established by Franza and Rochon 18 and later popularized by Mann and his colleagues. 19, 20 Cells are cultured in a medium supplemented with heavy amino acids ( 13 C or 15 N, containing lysine or arginine) for several passages to reach the maximum labeling efficiency. The labeled samples are pooled with cells grown in the normal medium, digested, and analyzed by tandem MS. The technique has been applied in various studies related to protein interactions, signaling, and dynamics in cell. Though it has a high potential, the method is limited to studies that involve cell cultures; however, a recent metabolic labeling study showed that the entire model organism (eg, rat) can be labeled by using labeled chow. The method is termed stable isotopelabeling in mammals. Yates and his coworkers demonstrated the strategy by using a 15 N-labeled rat in several differential proteomic and phosphoprotein analyses in various tissues like liver, brain, etc. [21] [22] [23] [24] SILAC mouse or stable isotope-labeling in mammals has been used for quantitative analysis of proteomes from mice to determine protein functions under complex in vivo conditions. The F2 generation of mice fed with a diet containing heavy lysine was found to be completely labeled in all organs tested by Kruger and colleagues. In this study, kindlin-3 has been identified as an essential factor for red blood cell function. 25 Very recently, another study of in-depth quantitative cardiac proteomics has been demonstrated by Heck et al in SILAC mouse. 26 They addressed the use of Lys-N and electron transfer dissociation to improve quantitative and qualitative yields of the left and right ventricular proteomes. Recently, Selbach and colleagues generated "SILAC flies" by feeding fruit flies (Drosophila melanogaster) with SILAC-labeled yeast. They have demonstrated that the SILAC fly can be used for accurate quantification of proteins in vivo. 27 All these studies have proved that the method is not limited to cell cultures anymore.
Another limitation of SILAC approach is that it does not work equally well for all cell types, especially for those that are unable to incorporate certain amino acids. Some cells are harder to grow in dialyzed serum, owing to the loss of essential growth factors. It has also been observed that arginine, one of the commonly used labeled amino acids, can be converted into proline during cell division, complicating the quantification process. 20 These limitations should be considered when selecting the SILAC approach for quantification studies.
In the chemical mass tagging approach, proteins or peptides are tagged with a stable isotope-containing molecule in vitro. Tagged peptides can be efficiently isolated and enriched with affinity groups attached to the tagging moiety that can bind to specific amino acids. Isotope-coded protein labeling, ICAT, and the recently developed isobaric tags for relative and absolute quantification (iTRAQ) and tandem mass tags (TMT) fall under this category. Isotope-coded protein labeling is based on tagging free amine groups of intact proteins using isotopically different nicotinoyl reagents (eg, 12 C 6 H 4 , 12 C 6 D 4 and 13 C 6 H 4 ). 28 Thus only lysine-containing peptides can be quantified, covering only 70% of quantification. ICAT technology involves chemical linking of an affinity group to cysteinyl residues on the protein. 29 The ICAT reagent consists of a sulfhydrylreactive iodoacetate group, a biotin affinity group, and a linker carrying light or heavy isotopes. Proteins are labeled using the sulfhydryl-reactive iodoacetate group; the biotin group allows affinity purification with avidin or streptavidin. After tagging, both the protein samples are pooled, digested, and enriched on an avidin affinity column to capture peptides containing tagged residues, which can be analyzed by subsequent tandem MS. The method has both advantages and limitations, owing to the specificity of the affinity tag to specific amino acid residues. On one hand, the sample complexity is reduced owing to targeted labeling and enrichment; on the other hand, quantification is possible to only a fraction of sample that contains cysteines, a relatively rare amino acid. In recent years, additional affinity tags have been developed, allowing specific binding to other amino acids; however, the enrichment step hinders the quantification of untagged proteins or peptides during the analysis.
In spite of its limitations, the method has been successfully used in several cardiovascular studies. One such study is to identify oxidant-sensitive cysteine thiols of proteins in rabbit heart membrane fractions that are sensitive to high concentration of hydrogen peroxide. 30 A few more studies described the superiority of ICAT compared with 2D gel electrophoresis by analyzing differential protein expression in rat brain endothelial cells affected by ischemic insult in vitro. The ICAT method could identify 138 proteins compared with 38 proteins by the 2D gel electrophoresis method, and, also, ICAT was observed to be reproducible and precise. 31 Another widely used approach in chemical tagging is through an isobaric linking technique, iTRAQ, which has been established as a more comprehensive and efficient method for protein quantification. The method was first developed by Ross et al 32 and was later commercialized by Applied Biosystems. It involves tagging of the NH 2 -terminal and side chain lysine amino groups, with stable isotopically labeled mass tags. The iTRAQ reagent consists of a reporter group with variable mass of 114 to 117 Da or 113 to 121 Da, a mass balance group, and an amine-specific reactive group. The different combinations of reporter and balance groups keep the uniform molecular weight of the combined molecule. Hence, even after labeling, the molecular weight of the peptides labeled with different isobaric tags remains the same and appears as a single peak in the initial MS scan. Further fragmentation of the peptide peak releases the reporter group that allows the distinction of the different samples and provides the necessary quantitative information. Owing to the possibility of generating multiple compounds, simultaneous labeling of multiple samples is made possible using a 4-plex or 8-plex kit. Thus, the technique overcomes the limitation of comparison between 2 samples only as can be seen in most of the other stable isotope-labeling techniques. The method can be used not only to perform relative quantification but also for AQUA by using an internal standard peptide labeled with 1 of the iTRAQ reagents. Although the method has been used extensively, the reagents are relatively expensive, and the reporter ions fall below the low-mass cutoff of ion-trap mass spectrometers. Hence, mass spectrometers that cover the whole spectrum ranging from low mass to high mass, enabling the measurement of both reporter ions and peptide fragments in the same MS spectrum, are required.
Owing to its extensive applicability, the iTRAQ method has already been adapted extensively in cardiovascular research. [33] [34] [35] [36] Chen and coworkers used this approach in a multiplex manner to discover candidate biomarkers for coronary artery disease from an apolipoprotein E (APOE)-knockout (APOE −/− ) mouse model. 33 A multiplexed quantitative analysis has been carried out on the iTRAQ-labeled plasma samples collected from wild-type and APOE −/− mice at 6 and 12 weeks after fat treatment. To increase the proteomic coverage and obtain the most comprehensive data, both MALDI and electrospray ionization (ESI) mechanisms are used along with the multidimensional separation of strong cation exchange or hydrophilic interaction liquid chromatography followed by reverse-phase liquid chromatography separation. Using the combined approach, a total of 628 proteins are identified, of which 621 were quantified by either MALDI or ESI methods. Of these, 76 proteins were comparably quantified using both approaches to find 3 upregulated and 9 downregulated proteins in plasma from APOE −/− mice.
Another study by Warren et al used combined iTRAQ labeling and off-gel fractionation prior to mass spectral quantification. 34 This improved protein identification by approximately 4-fold, which allowed them to identify 22 unique proteins in the sarcomeric-enriched fraction in acute myocardial ischemia. The iTRAQ method has also been used to study proteins related to aged myocardium. This study was performed on male Fisher 344 rats (4 months and 26 months old) to identify 1040 unique proteins, where a subset of 117 was differentially expressed in young versus aged hearts. Proteins unique to an aged ventricle compared with a young heart have been reported: the first report of its own kind. This work was carried out as a basis for future studies to compare the differential protein expression in an aged heart to that of other conditions related to heart failure. 35 Recent advancements in multiplexed quantitative approaches include another widely used labeling strategy: TMT. 37 The amine-reactive isobaric TMT reagents allow relative and AQUA of peptides similar to iTRAQ technology. Another addition to this technology is cysteine-reactive TMT reagents designed to specifically label cysteine-containing peptides, which enables thiol-targeted affinity enrichment, as in the ICAT method, but allows absolute and multiplexed (0 to 6-plex) quantification as in isobaric iTRAQ technology. 38 With the increased popularity of multiplexed tagging technology, several improvements in MS methodologies have been reported to increase the yield of data analyzed. One such study is carried out by Scherl and colleagues, by combining the low and high energy tandem mass spectra on an LTQ Orbitrap MS. 39 They combined collision-induced dissociation (CID) and higher-energy C-trap dissociation (HCD) to identify and quantify proteins efficiently with isobaric tagging technology. Human plasma proteins were TMT-labeled and analyzed by simultaneous CID and HCD modes, using LTQ Orbitrap MS to demonstrate the higher efficiency in terms of identification and quantification of proteins. As CID and HCD are carried out in parallel, there is no effect on overall duty cycle, thereby, making it more advantageous than performing CID or HCD alone. In order to analyze the data acquired in the CID/HCD mode, they developed informatics tools, which are available online (http://web.expasy.org/HCD_CID_merger.html).
Another study suggests an axial electric field in the HCD collision cell of LTQ Orbitrap increases the overall precision of quantification using isobaric tags. 40 The improvements were found to be consistent for both iTRAQ and TMT tags tested (iTRAQ 4-plex, iTRAQ 8-plex, and TMT 6-plex), suggesting the HCD collision cell with axial field is a well-suited approach for quantitative proteomics using isobaric tags.
Enzymatic incorporation of stable isotopes is another commonly used method that overcomes some of the challenges involved with other methods discussed above. This approach provides comprehensive and global proteomic quantification of both in vivo and in vitro samples. In this technique, both proteolytic cleavage and stable isotope (eg, 18 O) labeling occurs simultaneously during digestion. 41,42 18 O labeling generates peptides with either 2 Da or 4 Da heavier mass than their natural counterparts, owing to the exchange of 1 or both the oxygen atoms with 18 O at the carboxy terminus of the peptide. One of the major limitations in this method is the enzyme-mediated back-exchange of 18 O with 16 O, leading to complicated results. In addition, different peptides have different rates of labeling efficiency, increasing the complication in analysis. These complications can be limited by the use of immobilized trypsin, which can be removed after digestion/labeling to prevent back-exchange and also provide high concentration of enzyme to increase the labeling efficiency. Olivier and colleagues have developed protocols and analysis tools that allow the efficient quantitative analysis of complex biological samples using this approach. 43, 44 
Label-Free Quantification
Recent developments in the MS instrumentation, extensive advances in bioinformatics, and computing power facilitated alternate approaches to protein quantification by label-free methods. Label-free quantification overcomes the expensive and extensive workflows required in the labeling techniques. It is based on the correlation between peptide MS peak intensity and the abundance of the protein in a given sample. Several approaches are established like peptide/protein intensity measurements, which is known to be directly proportional to the ion concentration. 45 The spectral total-ioncurrent (TIC) method has been proposed for relative protein quantification between samples. In this approach, the average of the TIC for all of the MS/MS spectra that identify a protein is used for quantification. 46 A more widely used approach, called spectral counting, is based on counting the number of MS spectra assigned to a protein, to measure the protein abundance. An increase in protein abundance usually provides a larger number of proteolytic peptides, and vice versa. This, in turn, results in an increased number of unique peptides and the identified total MS/MS spectra for each protein, thereby, increasing the protein sequence coverage. 47 Based on this principle, quantification of proteins is performed using the spectral counting approach.
Without much sampling effort like derivatizing the peptides, a standard tandem MS analysis is carried out in a typical label-free quantification approach; however, owing to the fact that not all peptides are equally detectable, especially on account of ion suppression effects and inability to identify low abundance proteins due to large dynamic range of protein concentrations in any given sample, the method is not so simple. Use of multidimensional chromatography reduces these limitations to a certain extent. 48 The label-free quantification approach has been used to analyze proteomes from endomyocardial biopsies to identify differential protein expression in inflammatory dilated cardiomyopathy. 49 The study includes identification of 485 proteins, of which 174 were found to be differentially expressed, with at least 1.3-fold changes in intensity (P<0.05). Owing to the versatility of the method, this approach has also been used for quantification of phosphopeptides. Knepper and colleagues studied cyclic AMP/vasopressin-dependent signaling pathways in renal medullary thick ascending limb cells via a quantitative phosphoproteomics approach. The approach involved tryptic digestion and immobilized metal ion affinity chromatography enrichment, followed by tandem MS for label-free quantification. 50
Absolute Quantification
Although the global protein profiling relies on relative quantitative approaches, targeted analysis requires AQUA. Potential candidate biomarkers from discovery analysis must be verified by AQUA in patient samples before progressing to clinical validation. Selective detection and quantification of targeted proteins from complex biological mixtures (including, but not limited to, plasma or serum) is the goal of biomarker validation and therapeutic drug development.
The method involves addition of a known amount of a stable isotopic form of the target of interest to the sample solution. The absolute amount of unknown sample is measured from the relative signal intensities of the labeled compound versus unlabeled counterpart. Unlike the relative quantification methods described above, AQUA analysis requires qualitative analysis before the quantitative analysis to make sure the analyte is well-defined.
Targeted quantification using stable isotope-labeled internal standards has been in practice for more than 20 years. An increasing interest and greater success could be achieved in AQUA techniques, with the recent advances in MS instrumentation, especially with the improved sensitivity and accuracy, in addition to the advanced data analysis tools.
Selected reaction monitoring (SRM) is 1 of the most widely used methods of AQUA, the form of quantification where the precursor and fragment ion pairs are monitored, typically in a triple quadrupole (Q) instrument. [51] [52] [53] [54] A precursor ion of interest is first selected in Q 1 , based on its accurate mass, and transmitted for collision-induced dissociation in Q 2 . The resulting fragmented ions of the selected precursor ion are mass analyzed in Q 3 . These precursor-fragment transitions are used to quantify a peptide. This approach is highly sensitive and specific, owing to the tandem selectivity of both precursor and fragment ions in Q 1 and Q 3 . Several SRM ion pairs associated with multiple peptides can be targeted in a single experiment, which is called a multiple reaction monitoring (MRM) technique. 54 The AQUA approach in SRM or MRM includes spiking of a stable isotope-labeled peptide of the target analyte into the sample mixture, and the relative peak response of each of the compounds is used to quantify the target. Usually, AQUA is limited to a small number of preselected proteins, owing to the requirement of heavy isotope-labeled internal standards for each protein; however, this approach has recently been multiplexed to quantify a few tens to hundreds of analytes simultaneously in a single experiment. Kuzyk et al quantified 45 proteins in human plasma by LC-MRM/ MS analysis. 55 Of these, 31 proteins are identified to be putative biomarkers of cardiovascular disease.
To increase the sensitivity of MRM analysis, especially to quantify low-abundance proteins from complex mixtures, Anderson et al developed an immunoenrichment-based strategy called Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). 56 In this method, isotopically labeled peptides are added to the tryptic digest of the sample, followed by the addition of antipeptide antibodies that are bound to beads. Unbound peptides are washed away, and the peptides bound are eluted prior to quantification by MRM, using a triple quadrupole mass spectrometer. Carr and colleagues used the SISCAPA -MRM strategy to develop multiplexed assays for troponin-I, an established cardiac biomarker, and interleukin-33, an emerging cardiac biomarker, from plasma sample in cardiac injury patients. 57 Changes in concentration of these proteins, ranging from 1 to 10g/L in plasma, could be measured using this method.
AQUA by label-free approaches has also been demonstrated by a modified spectral counting method called absolute protein expression. It is a measure of protein concentration per cell calculated based on the proportionality between the protein abundance and the number of peptides observed. 58, 59 Perspectives Mass spectrometry has emerged as a powerful tool for the analysis of proteins over the last decade or more. Recent achievements in technological advancements and improved methodologies allow both qualitative and quantitative analysis of complex biological samples; however, the complete spectrum of protein differential expression in disease, or at a given state, is yet to be achieved but not far away, if the advancements in technology are achieved at a greater pace. With the available technology, it is possible to identify candidate biomarkers useful for the diagnosis of disease, along with the identification of novel therapeutic targets.
Several approaches for the identification of these biomarkers are established, which can be applied based on the need and applicability of the goal to be achieved. To date, there is no single method that can be recommended or applied for all protein quantification studies. The method of choice has to be decided based on the biological source of the sample, whether it is a tissue collected from biopsies, or cell culture etc. The aim to analyze either global or targeted differential expression in either absolute or relative quantification will decide the approach to be chosen. In addition, complexity of the samples, replication of the experiments, and cost of experiments have to be considered while selecting the quantification approach. The combination of different methods would give complementary results, thus increasing the credibility of the data. Combining multiple methods can be useful for verification and expanding proteome coverage in comprehensive protein characterization studies. 16, 17, 36 In addition to identifying unique biomarkers, several posttranslational modifications and their differential modifications can also be measured by the MS-based quantitative approaches. All this information on changes in protein expression and posttranslational modifications merged together will provide novel information beyond the genomic data. This enables understanding the regulators of disease processes, which can be used for better disease management.
While discussing the possibilities and achievements in this field, we should also consider some limitations involved in the technology, owing to complexity of proteomes, wide range of protein concentrations, reversible and dynamic posttranslational modifications, etc; however, these limitations can be overcome by further advancements in instrumentation, by improving the sensitivity, selectivity, and speed of analysis. In addition, improved methodologies from sample preparation strategies to instrumental methods to reduce protein loss and increased proteome coverage will facilitate greater success with large-scale protein characterization. Furthermore, not to forget, generating large datasets requires more sophisticated bioinformatics tools that can handle huge datasets.
